A bi-steric mTORC1-selective inhibitor overcomes drug resistance in breast cancer

Delong Meng(China XD Group (China)), Sourav Bandyopadhyay(University of California, San Francisco)
Oncogene
June 1, 2023
Cited by 15


Related Papers